Suneet Shukla

6.3k total citations
77 papers, 5.1k citations indexed

About

Suneet Shukla is a scholar working on Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Suneet Shukla has authored 77 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Oncology, 25 papers in Molecular Biology and 25 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Suneet Shukla's work include Drug Transport and Resistance Mechanisms (68 papers), Pharmacological Effects and Toxicity Studies (25 papers) and HIV/AIDS drug development and treatment (16 papers). Suneet Shukla is often cited by papers focused on Drug Transport and Resistance Mechanisms (68 papers), Pharmacological Effects and Toxicity Studies (25 papers) and HIV/AIDS drug development and treatment (16 papers). Suneet Shukla collaborates with scholars based in United States, China and India. Suneet Shukla's co-authors include Suresh V. Ambudkar, Robert W. Robey, Susan E. Bates, Zhe‐Sheng Chen, Chung‐Pu Wu, Michael M. Gottesman, Shinobu Ohnuma, Wanida Chearwae, Pornngarm Limtrakul and Rajendra Prasad and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Suneet Shukla

77 papers receiving 5.0k citations

Peers

Countries citing papers authored by Suneet Shukla

Since Specialization

Citations

This map shows the geographic impact of Suneet Shukla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suneet Shukla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suneet Shukla more than expected).

Fields of papers citing papers by Suneet Shukla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suneet Shukla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suneet Shukla. The network helps show where Suneet Shukla may publish in the future.

Co-authorship network of co-authors of Suneet Shukla

This figure shows the co-authorship network connecting the top 25 collaborators of Suneet Shukla. A scholar is included among the top collaborators of Suneet Shukla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suneet Shukla. Suneet Shukla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inclusion of Obese Participants in Drug Development: Reflections on the Current Landscape and a Call for Action 2023 ·The Journal of Clinical Pharmacology ·(unknown), Kenneth Todd Moore, Suneet Shukla, Karen Rowland Yeo, Karthik Venkatakrishnan	3
2	Exome Sequencing of ABCB5 Identifies Recurrent Melanoma Mutations that Result in Increased Proliferative and Invasive Capacities 2019 ·Journal of Investigative Dermatology ·(unknown), James P. Madigan, Jared J. Gartner, (unknown), Jimmy Lin, Nouar Qutob, Jitendra Narayan, Suneet Shukla, Suresh V. Ambudkar, Di Xia, Steven A. Rosenberg, Michael M. Gottesman, Yardena Samuels, Jean-Pierre Gillet	9
3	ABC Transporter-Mediated Multidrug-Resistant Cancer 2019 ·Advances in experimental medicine and biology ·Haneen Amawi, Hong‐May Sim, Amit K. Tiwari, Suresh V. Ambudkar, Suneet Shukla	192
4	Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells 2018 ·Cancer Letters ·Ning Ji, Yuqi Yang, Chao‐Yun Cai, Zi‐Ning Lei, Jing‐Quan Wang, Pranav Gupta, Suneet Shukla, Suresh V. Ambudkar, Dexin Kong, Zhe‐Sheng Chen	91
5	Regorafenib antagonizes BCRP-mediated multidrug resistance in colon cancer 2018 ·Cancer Letters ·Yunkai Zhang, Yi‐Jun Wang, Zi‐Ning Lei, Guan-Nan Zhang, Xiaoyu Zhang, De‐Shen Wang, (unknown), Suneet Shukla, Suresh V. Ambudkar, Amal Kaddoumi, Zhi Shi, Zhe‐Sheng Chen	39
6	Selective reversal of BCRP-mediated MDR by VEGFR-2 inhibitor ZM323881 2017 ·Biochemical Pharmacology ·Yunkai Zhang, Xiaoyu Zhang, Guan-Nan Zhang, Yi‐Jun Wang, (unknown), Dongmei Zhang, Suneet Shukla, Lili Liu, Dong‐Hua Yang, Suresh V. Ambudkar, Zhe‐Sheng Chen	27
7	Regorafenib overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter in colorectal cancer: In vitro and in vivo study 2017 ·Cancer Letters ·Yi‐Jun Wang, Yunkai Zhang, Guan-Nan Zhang, Sweilem B. Al Rihani, Meng-Ning Wei, Pranav Gupta, Xiaoyu Zhang, Suneet Shukla, Suresh V. Ambudkar, Amal Kaddoumi, Zhi Shi, Zhe‐Sheng Chen	64
8	Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1 2014 ·Biochemical Pharmacology ·Yi‐Jun Wang, Rishil J. Kathawala, Yunkai Zhang, Atish Patel, Priyank Kumar, Suneet Shukla, King Leung Fung, Suresh V. Ambudkar, Tanaji T. Talele, Zhe‐Sheng Chen	48
9	Hydrogel-assisted functional reconstitution of human P-glycoprotein (ABCB1) in giant liposomes 2014 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·(unknown), Haiyan Liu, (unknown), Suneet Shukla, David Sept, Suresh V. Ambudkar, Michael Mayer	25
10	Synthesis and biological evaluation of analogues of the kinase inhibitor nilotinib as Abl and Kit inhibitors 2012 ·Bioorganic & Medicinal Chemistry Letters ·Damien Duveau, Xin Hu, Martin J. Walsh, Suneet Shukla, Amanda P. Skoumbourdis, Matthew B. Boxer, Suresh V. Ambudkar, Min Shen, Craig J. Thomas	18
11	Sildenafil Reverses ABCB1- and ABCG2-Mediated Chemotherapeutic Drug Resistance 2011 ·Cancer Research ·Zhi Shi, Amit K. Tiwari, Suneet Shukla, Robert W. Robey, Satyakam Singh, In‐Wha Kim, Susan E. Bates, Xingxiang Peng, Ioana Abraham, Suresh V. Ambudkar, Tanaji T. Talele, Liwu Fu, Zhe‐Sheng Chen	152
12	Use of Baculovirus BacMam Vectors for Expression of ABC Drug Transporters in Mammalian Cells 2011 ·Drug Metabolism and Disposition ·Suneet Shukla, Candice Schwartz, Khyati Kapoor, (unknown), Suresh V. Ambudkar	40
13	The Skin Cancer Chemotherapeutic Agent Ingenol-3-Angelate (PEP005) Is a Substrate for the Epidermal Multidrug Transporter (ABCB1) and Targets Tumor Vasculature 2010 ·Cancer Research ·Luowei Li, Suneet Shukla, Andrew Lee, Susan H. Garfield, David J. Maloney, Suresh V. Ambudkar, Stuart H. Yuspa	68
14	Divergent signature motifs of nucleotide binding domains of ABC multidrug transporter, CaCdr1p of pathogenic Candida albicans, are functionally asymmetric and noninterchangeable 2010 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Antresh Kumar, Suneet Shukla, Ajeet Mandal, Sudhanshu Shukla, Suresh V. Ambudkar, Rajendra Prasad	15
15	The amino acid residues of transmembrane helix 5 of multidrug resistance protein CaCdr1p of Candida albicans are involved in substrate specificity and drug transport 2009 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·(unknown), (unknown), Monika Sharma, Suneet Shukla, Suresh V. Ambudkar, Rajendra Prasad	18
16	Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1® 2008 ·Biochemical Pharmacology ·Robert W. Robey, Suneet Shukla, (unknown), Robert K. Oldham, (unknown), Suresh V. Ambudkar, Tito Fojo, Susan E. Bates	130
17	Development of inhibitors of ATP-binding cassette drug transporters – present status and challenges 2008 ·Expert Opinion on Drug Metabolism & Toxicology ·Suneet Shukla, Chung‐Pu Wu, Suresh V. Ambudkar	216
18	New inhibitors of ABCG2 identified by high-throughput screening 2007 ·Molecular Cancer Therapeutics ·Curtis J. Henrich, Robert W. Robey, Heidi R. Bokesch, Susan E. Bates, Suneet Shukla, Suresh V. Ambudkar, Michael Dean, James B. McMahon	57
19	Disulfiram, an old drug with new potential therapeutic uses for human cancers and fungal infections 2005 ·Molecular BioSystems ·Zuben E. Sauna, Suneet Shukla, Suresh V. Ambudkar	78
20	Alanine scanning of transmembrane helix 11 of Cdr1p ABC antifungal efflux pump of Candida albicans: identification of amino acid residues critical for drug efflux 2005 ·Journal of Antimicrobial Chemotherapy ·Preeti Saini, Tulika Prasad, Naseem A. Gaur, Suneet Shukla, Sudhakar Jha, Sneha Sudha Komath, Luqman Ahmad Khan, Qazi Mohd Rizwanul Haq, Rajendra Prasad	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact